{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"medRxiv"}],"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T13:28:59Z","timestamp":1775827739886,"version":"3.50.1"},"posted":{"date-parts":[[2026,4,8]]},"group-title":"Epidemiology","reference-count":31,"publisher":"openRxiv","license":[{"start":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T00:00:00Z","timestamp":1775606400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.medrxiv.org\/about\/FAQ#license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2026,4,8]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:sec>\n                  <jats:title>Background<\/jats:title>\n                  <jats:p>Tuberculosis recurrence represents a substantial proportion of incident tuberculosis in many settings. Distinguishing between its mechanisms can inform public health interventions for prevention.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Methods<\/jats:title>\n                  <jats:p>We conducted a retrospective study of individuals with multiple culture-confirmed TB episodes and paired isolates collected between 2012 and 2023 in Dourados and Campo Grande, Mato Grosso do Sul, Brazil. Patients were classified as having recurrent TB after treatment completion or retreatment following non-curative outcomes. Whole-genome sequencing was used to assess pairwise genetic distances between isolates, classifying relapse or persistent infection (\u226412 single-nucleotide polymorphisms [SNPs]) versus reinfection or retreatment with reinfection (&gt;12 SNPs).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Results<\/jats:title>\n                  <jats:p>Among 9,293 individuals with TB, 772 recurrent or retreatment episodes were identified. Paired isolates were available for 82 individuals. Among those who completed treatment, reinfection accounted for 74.1% (40\/54) of recurrent episodes, while 25.9% (14\/54) were relapse. Among individuals with non-curative outcomes, persistent infection (53.6%, 15\/28) and retreatment with reinfection (46.4%, 13\/28) occurred at similar frequencies. Relapse and persistent infection occurred earlier after the initial episode, whereas reinfection predominated after two years. Incarceration history was strongly associated with reinfection both after treatment completion (92.5%, p=0.012) and non-curative outcomes (76.9%, p=0.016).<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Conclusions<\/jats:title>\n                  <jats:p>In this high-burden setting, reinfection is the main driver of TB recurrence after treatment completion, particularly at longer intervals, indicating ongoing transmission. Relapse and persistent infection remain clinically important, especially following non-curative outcomes. These findings underscore the need for integrated strategies combining adherence support to prevent treatment-related recurrence with interventions to reduce transmission, particularly in high-risk settings.<\/jats:p>\n                <\/jats:sec>\n                <jats:sec>\n                  <jats:title>Summary<\/jats:title>\n                  <jats:p>Whole-genome sequencing revealed that tuberculosis recurrence in Brazil is predominantly driven by reinfection, especially after treatment completion and at longer intervals, while relapse and persistent infection occur earlier and are linked to incomplete treatment, highlighting the need for combined treatment and transmission-control strategies.<\/jats:p>\n                <\/jats:sec>","DOI":"10.64898\/2026.04.07.26350349","type":"posted-content","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T01:25:18Z","timestamp":1775697918000},"source":"Crossref","is-referenced-by-count":0,"title":["Distinguishing Relapse from Reinfection in Recurrent Tuberculosis: A Genomic and Epidemiologic Study in Brazil"],"prefix":"10.64898","author":[{"given":"Paulo Cesar Pereira dos","family":"Santos","sequence":"first","affiliation":[{"name":"School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thais Oliveira","family":"Goncalves","sequence":"additional","affiliation":[{"name":"School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eunice Atsuko Totumi","family":"Cunha","sequence":"additional","affiliation":[{"name":"Laboratory of Mycobacteriology, Central Laboratory of Mato Grosso do Sul, Campo Grande, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharine S.","family":"Walter","sequence":"additional","affiliation":[{"name":"Division of Epidemiology, University of Utah, Salt Lake City, Utah, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0065-2204","authenticated-orcid":false,"given":"Evelyn Lepka","family":"de Lima","sequence":"additional","affiliation":[{"name":"Tuberculosis Control Program, Municipal Health Secretariat of Guaruj\u00e1 City, Guaruj\u00e1, S\u00e3o Paulo, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6665-6825","authenticated-orcid":false,"given":"Julio","family":"Croda","sequence":"additional","affiliation":[{"name":"School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil"},{"name":"Department of Epidemiology of Microbial Diseases, Yale School of Public Health, New Haven, Connecticut, USA"},{"name":"Fiocruz Mato Grosso do Sul, Funda\u00e7\u00e3o Oswaldo Cruz, Campo Grande, Mato Grosso do Sul, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason R.","family":"Andrews","sequence":"additional","affiliation":[{"name":"Stanford University, Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Crhistinne Cavalheiro Maymone","family":"Gon\u00e7alves","sequence":"additional","affiliation":[{"name":"School of Medicine, Federal University of Mato Grosso do Sul, Campo Grande, Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kesia Esther","family":"da Silva","sequence":"additional","affiliation":[{"name":"Stanford University, Department of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford, California, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2026041005200506000_2026.04.07.26350349v1.1","unstructured":"WHO. Global tuberculosis report 2025 [Internet]. Geneva: World Health Organization; 2025 p. 76. Available from: https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/e97dd6f4-b567-4396-8680-717bac6869a9\/content"},{"issue":"5","key":"2026041005200506000_2026.04.07.26350349v1.2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S1473-3099(03)00607-8","article-title":"Recurrence in tuberculosis: relapse or reinfection?","volume":"3","year":"2003","journal-title":"The Lancet Infectious Diseases. Elsevier"},{"key":"2026041005200506000_2026.04.07.26350349v1.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2021.12.344"},{"key":"2026041005200506000_2026.04.07.26350349v1.4","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-215449"},{"key":"2026041005200506000_2026.04.07.26350349v1.5","doi-asserted-by":"crossref","unstructured":"McIvor A , Koornhof H , Kana BD . Relapse, re-infection and mixed infections in tuberculosis disease. Pathog Dis. 2017; 75(3):ftx020.","DOI":"10.1093\/femspd\/ftx020"},{"key":"2026041005200506000_2026.04.07.26350349v1.6","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.1016\/j.ijid.2021.03.020","article-title":"Whole genome sequencing based differentiation between re-infection and relapse in Indian patients with tuberculosis recurrence, with and without HIV co-infection","volume":"113","year":"2021","journal-title":"International Journal of Infectious Diseases"},{"key":"2026041005200506000_2026.04.07.26350349v1.7","doi-asserted-by":"crossref","unstructured":"Baker MA , Harries AD , Jeon CY , et al. The impact of diabetes on tuberculosis treatment outcomes: a systematic review. BMC Med. 2011; 9:81.","DOI":"10.1186\/1741-7015-9-81"},{"key":"2026041005200506000_2026.04.07.26350349v1.8","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2019.07.016"},{"issue":"7","key":"2026041005200506000_2026.04.07.26350349v1.9","doi-asserted-by":"crossref","first-page":"e0220507","DOI":"10.1371\/journal.pone.0220507","article-title":"Smoking, alcohol use disorder and tuberculosis treatment outcomes: A dual co-morbidity burden that cannot be ignored","volume":"14","year":"2019","journal-title":"PLOS ONE. Public Library of Science"},{"key":"2026041005200506000_2026.04.07.26350349v1.10","first-page":"738","article-title":"Smoking adversely affects treatment response, outcome and relapse in tuberculosis","volume":"45","year":"2014","journal-title":"European Respiratory Journal"},{"key":"2026041005200506000_2026.04.07.26350349v1.11","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-64371-7_3"},{"key":"2026041005200506000_2026.04.07.26350349v1.12","doi-asserted-by":"publisher","DOI":"10.1086\/650528"},{"issue":"10","key":"2026041005200506000_2026.04.07.26350349v1.13","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S2213-2600(13)70231-5","article-title":"Whole-genome sequencing to establish relapse or re-infection with Mycobacterium tuberculosis: a retrospective observational study","volume":"1","year":"2013","journal-title":"The Lancet Respiratory Medicine"},{"key":"2026041005200506000_2026.04.07.26350349v1.14","doi-asserted-by":"publisher","DOI":"10.1016\/j.lana.2022.100186"},{"key":"2026041005200506000_2026.04.07.26350349v1.15","doi-asserted-by":"publisher","DOI":"10.1186\/s13073-019-0650-x"},{"issue":"4","key":"2026041005200506000_2026.04.07.26350349v1.16","first-page":"e000056","article-title":"SNP-sites: rapid efficient extraction of SNPs from multi-FASTA alignments","volume":"2","year":"2016","journal-title":"Microb Genom"},{"key":"2026041005200506000_2026.04.07.26350349v1.17","doi-asserted-by":"publisher","DOI":"10.1093\/molbev\/msaa015"},{"key":"2026041005200506000_2026.04.07.26350349v1.18","doi-asserted-by":"publisher","DOI":"10.1093\/bioinformatics\/bty633"},{"key":"2026041005200506000_2026.04.07.26350349v1.19","doi-asserted-by":"crossref","unstructured":"He W , Tan Y , Song Z , et al. Endogenous relapse and exogenous reinfection in recurrent pulmonary tuberculosis: A retrospective study revealed by whole genome sequencing. Front Microbiol. 2023; 14:1115295.","DOI":"10.3389\/fmicb.2023.1115295"},{"key":"2026041005200506000_2026.04.07.26350349v1.20","doi-asserted-by":"crossref","unstructured":"Li M , Qiu Y , Guo M , et al. Investigation on the cause of recurrent tuberculosis in a rural area in China using whole-genome sequencing: A retrospective cohort study. Tuberculosis. 2022; 133:102174.","DOI":"10.1016\/j.tube.2022.102174"},{"issue":"2","key":"2026041005200506000_2026.04.07.26350349v1.21","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S1473-3099(12)70277-3","article-title":"Whole-genome sequencing to delineate Mycobacterium tuberculosis outbreaks: a retrospective observational study","volume":"13","year":"2013","journal-title":"The Lancet Infectious Diseases. Elsevier"},{"issue":"6","key":"2026041005200506000_2026.04.07.26350349v1.22","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s15010-015-0759-9","article-title":"Exogenous reinfection of tuberculosis in a low-burden area","volume":"43","year":"2015","journal-title":"Infection"},{"key":"2026041005200506000_2026.04.07.26350349v1.23","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu574"},{"key":"2026041005200506000_2026.04.07.26350349v1.24","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200409-1200OC"},{"key":"2026041005200506000_2026.04.07.26350349v1.25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu186"},{"key":"2026041005200506000_2026.04.07.26350349v1.26","doi-asserted-by":"crossref","unstructured":"Barreto-Duarte B , Villalva-Serra K , Miguez-Pinto JP , et al. Retreatment and Anti-tuberculosis Therapy Outcomes in Brazil Between 2015 and 2022: A Nationwide Study. Open Forum Infect Dis. 2024; 11(8):ofae416.","DOI":"10.1093\/ofid\/ofae416"},{"issue":"10","key":"2026041005200506000_2026.04.07.26350349v1.27","doi-asserted-by":"crossref","first-page":"e0164172","DOI":"10.1371\/journal.pone.0164172","article-title":"Using Survival Analysis to Identify Risk Factors for Treatment Interruption among New and Retreatment Tuberculosis Patients in Kenya","volume":"11","year":"2016","journal-title":"PLOS ONE. Public Library of Science"},{"issue":"1","key":"2026041005200506000_2026.04.07.26350349v1.28","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s13104-018-3473-8","article-title":"Analysis of tuberculosis treatment outcomes among pulmonary tuberculosis patients in Bahawalpur, Pakistan","volume":"11","year":"2018","journal-title":"BMC Res Notes"},{"key":"2026041005200506000_2026.04.07.26350349v1.29","doi-asserted-by":"crossref","unstructured":"Carbone A da SS , Pai\u00e3o DSG , Sgarbi RVE , et al. Active and latent tuberculosis in Brazilian correctional facilities: a cross-sectional study. BMC Infect Dis. England; 2015; 15:24.","DOI":"10.1186\/s12879-015-0764-8"},{"issue":"10","key":"2026041005200506000_2026.04.07.26350349v1.30","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.5588\/ijtld.15.0126","article-title":"Prevalence of tuberculosis in prisons: risk factors and molecular epidemiology","volume":"19","year":"2015","journal-title":"Int J Tuberc Lung Dis. France"},{"issue":"11","key":"2026041005200506000_2026.04.07.26350349v1.31","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.jiph.2023.09.005","article-title":"The incidence of tuberculosis recurrence: Impacts of treatment duration of and adherence to standard anti-tuberculous therapy","volume":"16","year":"2023","journal-title":"Journal of Infection and Public Health"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.64898\/2026.04.07.26350349","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T12:20:22Z","timestamp":1775823622000},"score":1,"resource":{"primary":{"URL":"http:\/\/medrxiv.org\/lookup\/doi\/10.64898\/2026.04.07.26350349"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,8]]},"references-count":31,"URL":"https:\/\/doi.org\/10.64898\/2026.04.07.26350349","relation":{},"subject":[],"published":{"date-parts":[[2026,4,8]]},"subtype":"preprint"}}